Savara (SVRA) Interest & Investment Income (2010 - 2026)
Savara (SVRA) reported Interest & Investment Income of $1.1 million for Q1 2026, down 29.44% year-over-year from $1.5 million in Q1 2025, and down 11.55% on a QoQ basis from $1.2 million in Q4 2025.
Savara (SVRA) has 17 years of Interest & Investment Income data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Interest & Investment Income fell 29.44% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (down 43.72% YoY) and the FY2025 annual result came in at $4.2 million, down 35.64% from the prior year.
- Interest & Investment Income fell to $1.1 million in Q1 2026 per SVRA's latest filing, from $1.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.1 million in Q3 2024 and bottomed at -$570000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.1 million (2026), against an average of $943235.3.
- The widest annual swing landed in 2023, when Interest & Investment Income jumped 850.0%; it then sank 74.26% in 2025.
- Tracing SVRA's Interest & Investment Income over 5 years: stood at $614000.0 in 2022, then jumped by 147.39% to $1.5 million in 2023, then rose by 25.94% to $1.9 million in 2024, then plunged by 37.53% to $1.2 million in 2025, then decreased by 11.55% to $1.1 million in 2026.
- Per Business Quant, the three latest SVRA Interest & Investment Income figures stand at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $548000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 548,000.00 |
| Jun 30, 2025 | 921,000.00 |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 709,000.00 |
| Mar 31, 2023 | 765,000.00 |
| Dec 31, 2022 | 614,000.00 |
| Sep 30, 2022 | 152,000.00 |
| Jun 30, 2022 | -284,000.00 |
| Mar 31, 2022 | -570,000.00 |
| Dec 31, 2021 | -565,000.00 |
| Sep 30, 2021 | -566,000.00 |
| Jun 30, 2021 | -558,000.00 |
| Mar 31, 2021 | -593,000.00 |
| Dec 31, 2020 | -530,000.00 |
| Sep 30, 2020 | -459,000.00 |
| Jun 30, 2020 | -332,000.00 |
| Mar 31, 2020 | -160,000.00 |
| Dec 31, 2019 | -86,000.00 |
| Sep 30, 2019 | 5,000.00 |
| Jun 30, 2019 | 31,000.00 |
| Mar 31, 2019 | -20,000.00 |
| Dec 31, 2018 | 117,000.00 |
| Sep 30, 2018 | 111,000.00 |
| Jun 30, 2018 | -113,000.00 |
| Mar 31, 2018 | -104,000.00 |
| Dec 31, 2017 | -123,000.00 |
| Sep 30, 2017 | -277,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Dec 31, 2016 | 15,000.00 |
| Sep 30, 2016 | 31,000.00 |
| Jun 30, 2016 | 36,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 36,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Jun 30, 2015 | 32,000.00 |
| Mar 31, 2015 | 30,000.00 |
| Dec 31, 2014 | 19,000.00 |
| Sep 30, 2014 | 18,000.00 |
| Jun 30, 2014 | 17,000.00 |
| Mar 31, 2014 | 15,000.00 |
| Dec 31, 2013 | 17,362.00 |
| Sep 30, 2013 | 17,327.00 |
| Jun 30, 2013 | 10,895.00 |
| Mar 31, 2013 | 14,416.00 |
| Dec 31, 2012 | 17,260.00 |
| Sep 30, 2012 | 18,347.00 |
| Jun 30, 2012 | 19,285.00 |
| Mar 31, 2012 | 18,668.00 |
| Dec 31, 2011 | 14,365.00 |
| Sep 30, 2011 | 7,343.00 |
| Jun 30, 2011 | 10,998.00 |
| Mar 31, 2011 | 32,871.00 |
| Dec 31, 2010 | 24,867.00 |
| Sep 30, 2010 | 26,258.00 |
| Jun 30, 2010 | 23,308.00 |